Gilead

Nov 07, 2019

Sierra Oncology and Gilead Sciences Agree on Amendments to Asset Purchase Agreement for Momelotinib

Jul 12, 2019

Zydelig (idelalisib; Gilead) Drug Overview 2019: An Oral, Highly Selective Inhibitor of the Phosphoinositide 3-Kinase (PI3K) Isoform p110-delta

Jun 27, 2019

Letairis (ambrisentan; Gilead/GlaxoSmithKline) Market to 2025: A Selective Endothelin Type A Receptor Antagonist

Apr 02, 2019

Gilead Tops the Pharmaceutical Innovation Index for the First Time

Mar 14, 2019

Agenus Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Dec 20, 2018

Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies

Sep 25, 2018

Global Gene Therapy Market 2018-2022: Market to Grow at a CAGR of 22.42% with Biogen, Gilead, Novartis, Orchard Therapeutics & Spark Therapeutics Dominating

Jun 04, 2017

Human Immunodeficiency Virus Market (HIV) Global Analysis 2017-2021: Key Major Players are Johnson and Johnson, Merck, Gilead and GlaxoSmithKline Plc.